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Objectives: To estimate the prevalence and incidence of hepatitis B virus (HBV) infection among
patients attending three STD clinics in Pune, India, and to identify associated risk factors.
Methods: Of the 2098 patients screened at STD clinics in Pune during 1996, 497, who returned for
at least one follow up visit, were screened for various markers of HBV infection (HBsAg, anti-HBs, anti-
HBc), HIV antibody, and VDRL.
Results: Of the 497 participants 3.6%, 26.5%, and 43.2% were positive for HBsAg, anti-HBs, and
anti-HBc respectively. Tattooing (AOR 1.64, 95% CI 1.03 to 2.64) was found to be independently
associated with presence of core antibody. Additionally, history of being in commercial sex work and
history of a genital ulcer were independently associated with a positive anti-HBc antibody test (AOR
12.45, 95% CI 5.58 to 27.82 and AOR 1.70, 95% CI 1.09 to 2.66, respectively). 72 out of 497
(14.5%) participants were HIV positive at baseline. HIV-1 antibody positive patients were more likely
to have a positive anti-HBc test (69.4% v 39.0%, p<0.001). 30 out of 282 participants, negative for
anti-HBc antibody at enrolment, seroconverted subsequently, resulting in an incidence of 10.86 per
100 person years (95% CI 7.2%, 14.5%) (mean and accumulated follow up of 11.7 months and
276.17 person years, respectively).
Conclusions: A high prevalence and incidence of HBV infection, seen in STD clinic attendees under-
score the need to provide HBV vaccine to commercial sex workers and their clients in India.
Hepatitis B virus (HBV) infection is an important healthproblem in developing countries, including India.According to World Health Report 2000, it is estimated
that HBV infection accounts for about 600 000 disability
adjusted life years (DALY) and about 31 000 deaths annually
in South East Asia. About 4% of the population are estimated
to be carriers of HBV, giving a total pool of approximately 36
million carriers in India.1 HBV is reported to be responsible for
70% of cases of chronic hepatitis and 80% of cases of cirrhosis
of the liver. About 80% of Indian patients with hepatocellular
carcinoma have hepatitis virus associated liver disease.2
HBV infection is predominantly acquired at an early age in
developing countries, which includes vertical transmission
from mother to child, perinatal transmission, and horizontal
transmission from child to child. However, HBV can also be
transmitted sexually and sexual transmission—both hetero-
sexual and homosexual, accounts for a majority of the trans-
mission occurring in adult life.3
Numerous studies4–7 have reported high prevalence of HBV
markers in subjects practising risky sexual behaviour, like STD
patients and commercial sex workers. A high prevalence of
HBV infection has also been reported among individuals prac-
tising risky behaviours and HIV infected individuals in
India.8–10 However, a majority of such reports were based on
the presence of HBV surface antigen only. Though spouses of
HBV carriers were shown to have higher risk of HBV
acquisition,11 limited data are available with regard to the
extent of sexual transmission of HBV. Data on incidence of
HBV infection in STD patients and other population are not
available from India.
HBV as well as HIV can be transmitted sexually. Dual infec-
tion of HIV and HBV can lead to reactivation of HBV infection
and also increase in replication of HIV.12 Currently, STD control
programmes in India do not generally include administration
of hepatitis B vaccine to STD patients. Therefore, this study
was undertaken to assess the prevalence and incidence of
hepatitis B infection, as well as the HBV risk determinants
among patients attending three urban STD clinics in Pune.
MATERIAL AND METHODS
Study population and clinical methods
During the calendar year 1996, a total of 2098 patients visited
three STD clinics of the National AIDS Research Institute in
Pune. As a part of the ongoing study of HIV transmission
among people with high risk behaviour, these patients were
offered serological screening for HIV-1 and HIV-2 infection
and STD diagnosis and treatment. People seronegative for HIV
were invited to participate in a prospective study of HIV
acquisition and instructed to return every 3 months for follow
up. Seropositive patients were also encouraged to come for
follow up. After informed consent, patients were administered
a structured questionnaire, which included data on demo-
graphics, STD and medical history, sexual behaviour, and
reproductive history in female patients. Presumptive diagnosis
of sexually transmitted disease was based on detailed physical
examination and clinic based laboratory tests. The diagnosis
and treatment of STDs was administered in accordance with
WHO guidelines.
Of the 2098 patients screened in the STD clinics, 497
(23.7%), who returned for at least one follow up visit till
December 1998, were included in the present analyses.
HIV and syphilis serology
Baseline and follow up samples of participants were initially
screened with a commercially available enzyme linked
immunosorbent assay (ELISA) for detection of antibodies to
HIV-1 and HIV-2 (Genetic Systems Corporation, USA). Speci-
mens reactive in ELISA were evaluated by a rapid test for
HIV-1 and HIV-2 (Recombigen HIV-1/HIV-2 Rapid test Device,
Cambridge Biotech) and those found positive were confirmed
by the respective HIV-1 or HIV-2 western blot (Diagnostic Bio-
technology Ltd, Singapore). Syphilis antibodies were detected
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by standard Venereal Disease Research Laboratory non-
treponemal test (VDRL antigen, Span Diagnostic, Surat,
India).
HBV serology
Baseline samples of all participants were tested for the follow-
ing HBV markers by commercially available ELISA assays,
HBsAg (Surase B-96, General Biologicals, Taiwan), anti-HBs
(Anti Surase B 96, General Biologicals, Taiwan), and anti-HBc
(Abbott, USA). Follow up samples of patients, who were nega-
tive for HBV markers at baseline, were tested similarly for
respective markers. A subset of patients who, at enrolment,
were positive for anti-HBc antibody only, were tested for the
presence of anti-HBc IgM (Abbott, USA) to determine what
proportion of them were recent infections.
Statistical analysis
Baseline characteristics of the subjects who were followed at
the clinics were compared with those who never returned to
the clinics for follow up. Univariate analysis was performed to
assess the relation between various risk factors and anti-HBc
antibody in contingency tables with χ2 tests using the EPI-INFO
2000 package. Odds ratios were calculated. Variables found to
be significantly associated with presence of anti-HBc antibody
were included inmultivariate analysis using SPSS 10.0 package.
HBV incidence rates were estimated by the ratio of the
number of anti-HBc seroconversions to the person years of
follow up expressed as percentage. The risk factors associated
with anti-HBc conversion were analysed using EPI-INFO 2000.
Variables found to be significantly or marginally associated
with anti-HBc conversion were included in Cox proportional
hazard analysis using S-PLUS 2000. For the variables related to
sexual behaviours, Cox analysis was done separately for males
and females.
RESULTS
Of the 2098 subjects screened during the year 1996, 497 par-
ticipants, who completed at least one follow up by December
1998,were retrospectively enrolled in the study. These subjects
were compared with the remaining 1601 subjects who
attended clinics during the same period but only once. The two
populations did not differ significantly by most socio-
demographic and behavioural characteristics, including me-
dian age, sex,marital status,whether living alone (or not), and
sexual behaviour such as visit to sex worker, being in the com-
mercial sex work, number of sexual partners, condom use,
STD history. However, people who reported for follow up and
hence were included in the study were more likely to be liter-
ate (OR 1.55; 95% CI 1.21 to 1.99), non-smokers (OR 0.61; 95%
CI 0.49 to 0.76) and more likely to have undergone surgery
(OR 1.47; 95% CI 1.17 to 1.85).
Table 1 Univariate analysis of risk factors and prevalent anti-HBc antibody in STD
patients
Characteristic
No of
subjects
Prevalence of
anti-HBC (%) Odds ratio (95% CI) p Value
Overall 497
Risk group:
Female/non-sex worker 32 8 (25.0) 1.0
Female/sex worker 79 69 (87.3) 20.7 (7.3 to 58.5) <0.001
Male/no exposure to sex worker 44 12 (27.3) 1.0
Male/visited sex worker 342 126 (36.8) 1.6 (0.7 to 3.3) 0.215
Age (years):
<20 68 17 (25) 1.0
20–29 239 92 (38.5) 1.9 (1.0 to 3.4) 0.042
> 30 190 106 (55.8) 3.8 (2.0 to 7.0) <0.001
Marital status:
Never married 225 85 (37.8) 1.0
Married 212 82 (38.7) 1.0 (0.7 to 1.5) 0.846
Widowed/divorced 60 48 (80.0) 6.6 (3.3 to 13.1) <0.001
Formal education:
Some 393 141 (35.9) 1.0
None 104 74 (71.2) 4.4 (2.7 to 7.1) <0.001
Lifetime number of sexual partners:
1 67 14 (20.9) 1.0
2–9 259 91 (35.1) 2.0 (1.1 to 3.9) 0.028
10–999 87 42 (48.3) 3.5 (1.7 to 7.3) 0.001
> 1000 84 68 (81.0) 16.1 (7.2 to 35.9) <0.001
Condom use in past 3 months:
No 247 92 (37.2) 1.0
Yes 167 95 (56.9) 2.2 (1.5 to 3.3) <0.001
Tattooed:
No 303 104 (34.3) 1.0
Yes 194 111 (57.2) 2.6 (1.7 to 3.7) <0.001
History of genital ulcer:
No 295 111 (37.6) 1.0
Yes 202 104 (51.5) 1.7 (1.2 to 2.5) 0.002
Table 2 Logistic regression analysis of risk factors
and prevalence of anti-HBc antibody in STD patients
Characteristic AOR (95% CI) p Value
Risk group
Male/no exposure to sex worker 1.00
Male/visited sex worker 1.21 (0.58 to 2.51) 0.609
Female/non-sex worker 0.64 (0.22 to 1.91) 0.426
Female/sex worker 11.21 (4.25 to 29.52) <0.001
Age group
<20 years 1.00
20–29 years 1.71 (0.87 to 3.36) 0.117
>30 years 2.71 (1.36 to 5.40) 0.005
Tattooed
No 1.00
Yes 1.67 (1.09 to 2.55) 0.019
History of genital ulcer
No 1.00
Yes 1.70 (1.12 to 2.56) 0.012
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Of the 497 subjects included, 386 (77.7%) were males and
111 (22.3%) were females. Among women 79 (71.1%) were
engaged in commercial sex work. Two hundred and thirty nine
(48%) belonged to 20–29 years age group and 38% were aged
30 years or more. Nearly 45% were unmarried and a majority
(79%) had some formal education.
The overall prevalence of HBV markers was seen to be high
for HBsAg (3.6%; 95% CI 2.2 to 5.7), anti-HBs (26.5%; 95% CI
22.5 to 30.5%), and anti-HBc (43.2%; 95% CI 39.1 to 47.9%). A
total of 244 (49.1%) participants revealed at least one of the
HBV markers.
Table 1 summarises the results of univariate analysis of
prevalence of HBV core antibody among these patients. Odds
ratios in relation to appropriate baseline characteristics were
calculated.
Determinants such as living with family, sexual orientation,
history of anal sex in past 3 months, history of injections in
past 6 months, history of blood transfusions, circumcision,
current STDs (presence of genital ulcer, discharge, or warts),
and VDRL reactivity were not associated with positive
anti-HBc status.
Females practising sex work, and people who were older,
uneducated, tattooed, widowed, or divorced and who had suf-
fered from genital ulcer were more likely to possess anti-HBc
antibodies. A dose-response relation was observed when anti-
HBc prevalence was compared with number of lifetime
partners. Individuals who had used condoms in the last 3
months were not protected from HBV exposure.
Logistic regression analysis (table 2) revealed that tattooing
(AOR 1.67; 95% CI 1.09 to 2.55) and age more than 30 years
(AOR 2.71; 95% CI 1.36 to 5.40) were independently
associated with presence of anti-HBc antibody. Factors related
to sexual behaviour such as being a commercial sex worker
(AOR 12.45; 95% CI 5.58 to 27.82) and history of genital ulcer
(AOR 1.7; 95% CI 1.09 to 2.66) were also independently asso-
ciated with anti-HBc antibody.
Hepatitis B incidence
Two hundred and eighty two subjects who were negative for
anti-HBc antibody at enrolment were followed for a mean of
11.7 months (range 0.5–34.7 months) accumulating 276.17
person years of follow up. Thirty of these individuals serocon-
verted during the follow up giving an incidence of 10.86 per
100 person years (95% CI 7.2 to 14.5 per 100 person years).
Among those who seroconverted five were females and 25
were males.
Univariate analysis for risk determinants associated with
incident HBV infections (table 3) revealed that history of
tuberculosis (p value 0.0091) was found to be significantly
associated with HBV incidence. History of injections in past 6
months (p value 0.0079) did not increase the risk of acquiring
HBV infection. Additionally, a history of inguinal swelling also
(p value 0.0571) revealed borderline significance. However,
none of the sexual behaviour related variables were signifi-
cantly associated with HBV seroconversion. A high relative
risk (3.19, 95% CI (0.91 to 11.17)) was observed for men
involved in anal sex with commercial sex worker. All the above
variables were included in Cox proportional hazards analysis.
However, because of a very small number of conversions dur-
ing follow up, none of the variables except for males involved
in anal sex with commercial sex worker (p value 0.012)
showed any significance. This may possibly be the result of a
very small number of conversions during follow up or due to
the fact that none of these factors are independent risk factors
for incident HBV infection in adult STD patients.
Table 3 Univariate analysis of risk factors and incident anti-HBc antibody in STD
patients
Characteristic No of subjects
Incident HBV
core antibody
RR (CI) p ValueNo (%)
Overall 282 30 (11)
History of tuberculosis
Yes 9 4 (44.4) 4.65 (2.05 to 10.52) 0.0091
No 272 26 (9.6) 1.00
History of medical injections in past 6 months
Yes 135 7 (5.2) 0.33 (0.15 to 0.75) 0.0079
No 147 23 (15.6) 1.00
History of inguinal swelling
Yes 41 8 (19.5) 2.13 (1.02 to 4.45) 0.0571
No 240 22 (9.2) 1.00
Table 4 HBV marker profile at baseline and probable clinical staging
Clinical stage of HBV infection
HBV marker
No of subjects
(%)HBsAg Anti-HBs Anti-HBc
Early acute infection Pos Neg Neg 9 (3.7)
Either acute or chronic Infection Pos Pos/Neg Pos 9 (3.7)
Possibilities include: Neg Neg Pos 95 (39.0)
1 HBV infection in remote past
2 “Low level” HBV carrier
3 “Window” between disappearance of
HBsAg and appearance of anti-HBs
4 False positive reaction
Indicates previous HBV infection and
immunity to HBV infection
Neg Pos Pos 111 (45.5)
Vaccine type response Neg Pos Neg 20 (8.2)
Total 244
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Association of HIV and HBV infection at baseline
Among the participants, HIV prevalence was 14.5% (72/497,
95% CI 11.7 to 18.1%) with 32.4% in females and 9.6% in
males. Prevalence of HBV markers was higher in HIV positive
subjects compared with HIV negative subjects. The differences
were significant with respect to anti-HBc (69.4% v 38.8%; p
value <0.001) and anti-HBs (36.1% v 24.9% p value 0.065).
HIV infected individuals were four times (OR 3.95; 95% CI
2.19 to 7.18) more likely to have at least one positive marker of
HBV infection.
Based on the presence of various combinations of HBV
markers at baseline,13 we classified our subjects into different
stages of HBV infection. Of the 244 subjects who were found
to harbour at least one serological marker of HBV, at least 3.7%
subjects were more likely to be in early acute infection and
3.7% subjects may be in an acute or chronic infection state
(table 4). Thirty nine per cent were positive for anti-HBc alone
(n=95) at baseline. Anti-HBc alone positivity was signifi-
cantly higher among HIV positives compared to HIV negatives
(32.8% v 16.7%, p<0.01). Of these, 9.5% were found to be
positive for anti-HBc IgM antibody indicating recent infection.
DISCUSSION
In countries where HBV infection is endemic, it is transmitted
predominantly in childhood mostly through the parenteral
route. However, it can also be transmitted through the sexual
route. Predominant route of transmission also depends on the
proportion of people indulging in the practice of “at-risk”
behaviour. The HIV epidemic is reaching the general
population and rural areas in India. The level of the HIV epi-
demic in the country is probably indicative of a high
proportion of people practising at-risk behaviours. With this
background it is possible that a significant transmission of
HBV occurs through the sexual route. Though a high
prevalence of HBV infection is documented earlier, the
incidence of HBV infection among STD clinic attendees has
not been previously reported from India. A high overall preva-
lence of all three HBV markers—namely, HBsAg, anti-HBs,
anti-HBc, was seen in our study population. Similar high
prevalence has also been reported among STD clinic attendees
in some studies4–10 and in spouses of HBV carriers.11 Some of
these studies reported comparatively lowHBsAg carrier rate in
the non-STD population—for example, 0.64% in voluntary
blood donors.10 Tattooing is known to be independently
associated with prevalent anti-HBc antibody. Independent
association of anti-HBc prevalence with sexual risk factors
such as being a commercial sex worker and history of genital
ulcer support that HBV transmission through the sexual route
may be significant even in a country where HBV is an endemic
infection.
A high incidence (10.86 per 100 person years) of HBV
infection was detected among STD attendees in our study. This
estimated incidence of HBV is higher than that reported in
injecting drug users in Switzerland (2.1% per 100 person
years),14 and in Australia (1.8 per 100 person years).15 HBV
incidence observed in our study population was also higher
than that reported in men having sex with men (MSM) in
Brazil (4.44 per 100 person years).16 Among the sexual behav-
iour variables, “anal sex in males with commercial sex work-
ers” only was found to be associated with incident HBV infec-
tion. One important reason for lack of association of other
sexual behaviour factors could be small number of incidence
cases and the study setting where majority of the individuals
have practised unsafe sex.
A history of tuberculosis was found to increase the
likelihood of seroconversion for anti-HBc antibody. In this ret-
rospective study, our study instruments did not seek
additional information. It is therefore not possible to explain
this association with the available data. Inguinal lymphadeni-
tis can occur among patients having lymphogranuloma
venereum, chancroid, herpes genitalis, syphilis, and granu-
loma inguinale. This association between inguinal swelling
and incident HBV infection suggests that sexual transmission
of HBV might be playing an important part among adults.
History of injections in the last 6 months did not increase
the risk of acquiring HBV infection. Though, in fact, it
appeared to protect the subjects from acquiring HBV infection,
the association does not appear to be causal, as it does not have
any pathophysiological basis.
Prevalence of HBV markers in HIV positive subjects was
higher compared to that in HIV negative subjects. This differ-
ence was significant with respect to anti-HBc (69.4% v 38.8%)
and anti-HBs (36.1% v 24.7%). Similar findings were noted in
many other studies.17–20
HIV and HBV share the same routes of transmission. In
Pune, the overall HIV incidence has been reported to be 10.2%
per year,21 which is more or less similar to that estimated for
HBV infection in the same cohort. Interestingly, we have
reported among other factors, old age, commercial sex work,
lifetime number of sexual partners, current or previous geni-
tal ulcer/discharge/warts, and lack of formal education as the
risk determinants of prevalent HIV infection21; some of these
were found to be associated for HBV infection. The majority of
study subjects had no other known risk factor, except at-risk
sexual behaviour. Almost similar rates of incidence in both
these infections that are transmitted sexually underscore the
need for recognition of HBV as an important STD.
Among the subjects possessing any of the HBV markers,
23% were found to be HIV infected and 73.6% HIV infected
subjects possessed at least one of the three HBV markers. This
can be attributed to increased persistence and/or reactivation
of HBV infection among HIV infected people. However, it may
also be indicative of a greater efficiency of HBV transmission
through the sexual route compared to that of HIV. This has
important implications with regard to HIV transmission in
couples, as reported previously. Suriyanan et al found HIV
seropositivity in females to be significantly associated with
HBsAg positivity in the male index in couple setting.22
Coinfection with HIV can adversely affect HBV infection.
Coinfection with HIV may lead to increased chances of
persistence of HBV,23 24 increased HBV viral load,25 26 reduced
response to HBV treatment,27 and increased chances of
reactivation.28 This highlights the importance of prevention of
HBV infection at all settings including STD clinic.
The study population comprised the subjects who attended
follow up visits. The majority of the demographic characteris-
tics and sexual behaviour factors did not differ significantly
between study subjects and those who could not be enrolled
since they did not come for follow up, thereby indicating that
the study subjects represented STD clinic attendees in general.
However, people who reported for follow up and hence were
enrolled in the study were more likely to be literate (p=
<0.001), non-smokers (p<0.001), and more likely to have
undergone surgery (p<0.001). This suggests that our esti-
mates of HBV prevalence could be an underestimate of the
actual prevalence among STD patients. As against this, inclu-
sion of HIV positive (14%) subjects in our studymight have led
to overestimation of prevalence and incidence of HBV
infection.
Wewere interested to knowwhat proportion of the subjects,
positive for HBV markers at screening (244), were exposed in
the recent past. Eighteen (7.3%) possessed surface antigen.
However recency of infection in them cannot be confirmed in
absence of additional data on anti-HBc IgM, HBeAg, or HBV
DNA. Ninety five (39%) were positive for anti-HBc alone. This
is not a typical HBV serology; however, we had similar results
in our previous experience in the population in HBV endemic
region. Additional tests undertaken then had ruled out the
false positivity of anti-HBc in them. Additionally, anti-HBc
alone positivity was significantly higher among HIV positives
compared to HIV negatives (32.8% v 16.7%, p<0.01), which
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may have been due to impaired immune status of HIV
positives. Of the 95 subjects, nine were found to be positive for
anti-HBc IgM, indicating probable recent infection.
To summarise, a high prevalence and incidence of hepatitis
B virus infection was seen in STD clinic attendees. Some
sexual risk factors were independently associated with preva-
lent anti-HBc antibody. These results suggest evidence of
sexual transmission of HBV in India. HBV is a vaccine
preventable infection and the results highlight the importance
of HBV vaccination among commercial sex workers and their
clients.
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Key messages
• High prevalence and incidence of HBV infection was
observed in STD clinic attendees in Pune, India
• Extent of clinical interaction between HBV and HIV
coinfected individuals may have to be studied
• Sexual transmission may have a significant contribution in
spread of HBV
• Vaccination against HBV in sex workers and their clients
needs consideration
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